Universal Access and Affordable Medicines
Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.
About our work on access to medicines
Publications
EPHA Position on Medicine Shortages
EPHA Response to public consultation on EMA Regulatory Science to 2025
BeNeLuxA et al.: the best is yet to come
Latest Developments
Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs
Ahead of the upcoming hearing on the #EUVaccinesStrategy, public health organisations, not-for-profit healthcare insurers, healthcare professionals call for more transparency and fair return on public investment in vaccines
MEPs vote for action on medicines shortages – what should be the next steps?
Joint statement supported by EPHA following MEPs’ vote on medicines shortages report
Public health must be the leading priority of Europe’s pharmaceutical sector
new recommendations from civil society on how public interest and public health should prevail as leading priorities when regulating the pharmaceutical sector.
Analysis & Opinion
Will pharma commit to delivering affordable therapeutics against COVID-19?
The coronavirus disease offers pharma companies the possibility for public trust in them to be restored. It remains to be seen if they will grasp this chance.
The Top 4 Issues in Medicines Policy for 2020
A snapshot of the themes and trends which will dominate the EU pharmaceutical policy in 2020.
EU Review of Pharmaceutical Incentives – An Opportunity for Change
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EU
Get monthly updates on key public health issues!
Events
Time for a new deal
14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Past events
Putting health first
3 June 2019
Trailblazers, routes to better and affordable medicines by 2025
20 November 2018
How good are our medicines?
3 October 2018
Game changers for better and affordable medicines in Europe
21 November 2017
At the European Health Forum Gastein
How good are our medicines? An operational agenda for EU & national policy-makers
Medicines: new games, new rules - Pathways to better and affordable medicines.
“Healthy" innovation: putting patients before profits
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
Yannis Natsis
Policy Manager
yannis@epha.org
+32 2 233 3886